Replacement of the C6ORF66 assembly factor (NDUFAF4) restores complex I activity in patient cells.
about
Global profiling of co- and post-translationally N-myristoylated proteomes in human cellsIntracellular Delivery of Proteins with Cell-Penetrating Peptides for Therapeutic Uses in Human DiseaseCell-permeable protein therapy for complex I dysfunctionTherapeutic applications of the TAT-mediated protein transduction system for complex I deficiency and other mitochondrial diseases.Breaking in and busting out: cell-penetrating peptides and the endosomal escape problem.NDUFAF4 variants are associated with Leigh syndrome and cause a specific mitochondrial complex I assembly defect.Import of TAT-conjugated propionyl-CoA carboxylase using models of propionic acidemia.
P2860
Q24304441-E22FF1ED-F5C4-47A5-B027-CB4B4A0DE72CQ26767093-8A432021-8D34-4036-95A6-E2267F6762CBQ35660914-409CD459-F803-4855-BE5A-4B46A7CF7D1CQ38566683-E0933838-4911-427F-B0B1-7E150A41C525Q42255378-50CA76E7-01CC-4E13-B829-611C6FB70924Q47788849-E09A0AB8-716A-4C31-A57B-D9E6A9C14C71Q49597712-D26E2372-53F7-454F-BAF7-B8B019CDFBBF
P2860
Replacement of the C6ORF66 assembly factor (NDUFAF4) restores complex I activity in patient cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Replacement of the C6ORF66 ass ...... x I activity in patient cells.
@en
type
label
Replacement of the C6ORF66 ass ...... x I activity in patient cells.
@en
prefLabel
Replacement of the C6ORF66 ass ...... x I activity in patient cells.
@en
P2093
P2860
P1433
P1476
Replacement of the C6ORF66 ass ...... x I activity in patient cells.
@en
P2093
Dana Marcus
Haya Lorberboum-Galski
Michal Lichtenstein
P2860
P2888
P304
P356
10.2119/MOLMED.2012.00343
P407
P50
P577
2013-07-24T00:00:00Z
P5875
P6179
1068965587